Rigel Announces Third Quarter 2008 Financial Results and Clini...(09 ...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Rigel Announces Third Quarter 2008 Financial Results and Clinical Update
Date:11/3/2008
09
$6,036 $2,794 $17,801 $9,121
SUMMARY BALANCE SHEET DATA
(in thousands)
September 30, December 31,
2008 2007(1)
(unaudited)
Cash, cash equivalents and
available for sale securities $160,358 $108,296
Total assets 168,577 115,789
Stockholder's equity 130,740 82,182
(1) Derived from audited financial statements
'/>"/>
| SOURCE Rigel Pharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Rigel to Host Update Conference Call
2. Rigel Announces Fourth Quarter and Year End 2007 Financial Results
3. Rigel to Present at BIO CEO & Investor Conference
4. Rigel Announces Pricing of Public Offering of Common Stock
5. Rigel to Present Research Programs at Scientific Conferences
6. Rigel to Present at BIO Investor Forum 2007
7. 3SBio Inc. Announces Preliminary Third Quarter 2008 Results
8. VNUS Medical Technologies, Inc. Announces the Hiring of Guido Smeets, MD, as Vice President of Clinical Research and Chief Medical Officer
9. OriGene Announces 37,000 ORF cDNA Clones in a GFP Vector
10. Sharps Compliance Corp. Announces Appointment of John R. Grow as President and Chief Operating Officer
11. BMP Sunstone Announces Participation in November Investor Conferences
Post Your Comments:
Breaking Biology Technology:Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner 2CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner 3Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 2Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 3Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 4Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 2Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 3
[0] Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics[0] CSOFT's MedL10N Hires Beckman Coulter Veteran Tammy Werner [0] Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009[0] Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas
Other Biology Technology:Jovianna DiCarlo Named ConsentSolutions, Inc. President & Chief Executive Officer 2Recent Graduates Finding BioTech & Pharmaceutical Jobs Easier Than Ever With The Launch of CampusRXBio 2Recent Graduates Finding BioTech & Pharmaceutical Jobs Easier Than Ever With The Launch of CampusRXBio 3
Breaking Biology News(10 mins):Copying mother nature's designs 2Doctors May Be Able to Predict Domestic Abuse 58545 1Doctors May Be Able to Predict Domestic Abuse 58545 2New Study Highlights Injury Patterns in Collegiate Swimmers 58542 1New Study Highlights Injury Patterns in Collegiate Swimmers 58542 2Prodigy Diabetes Care LLC Expands Global Reach to European Diabetes Patients 58540 1Prodigy Diabetes Care LLC Expands Global Reach to European Diabetes Patients 58540 2
Other Biology News:Too few women scientists achieving academic leadership positions 2Blood clotting protein linked to rheumatoid arthritis 2Purdue research finds similarities in dog, human breast cancer pre-malignant lesions 2Purdue research finds similarities in dog, human breast cancer pre-malignant lesions 3Purdue research finds similarities in dog, human breast cancer pre-malignant lesions 4
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |